Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 2 Phase NA 1 Phase 3 1 Phase 2 1

Status

Completed 5 Unknown 4 Terminated 3 Withdrawn 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Intractable 1 Agnosia 1

Interventions

Cisplatin 22 Carboplatin 15 Radiotherapy 13 Paclitaxel 11 Gemcitabine 10 Rituximab 9 Fluorouracil 9 Drug Therapy 6 Dexamethasone 5 Cyclophosphamide 5 Capecitabine 5 Bevacizumab 5 Vinorelbine 4 Pemetrexed 4 Nivolumab 4 Methotrexate 4 Etoposide 4 Docetaxel 4 Bendamustine Hydrochloride 4 spartalizumab 3 pertuzumab 3 pembrolizumab 3 fludarabine 3 Vincristine 3 Trastuzumab 3 Surgical Procedures, Operative 3 Standard of Care 3 Prednisone 3 Oxaliplatin 3 Lenalidomide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Withdrawn × Ketamine × Clear all

NCT01951911 2017-07-11

KETA-1

Haukeland University Hospital

Phase 3 Withdrawn

Agnosia, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡